However, the concomitant effects of reducing mTOR signaling by rapamycin on plaques and tangles and on the associated learning and memory deficits have not been addressed nor has it become clear whether rapamycin may affect AD-like pathology in old mice. The gene discussed is MTOR; the disease is Alzheimer disease.